Ancilia Biosciences, Inc. research brief
CIK 1975776
Generated Nov. 19, 2026, 7:26 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: NEW YORK New York. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- April 6, 2026 · D · 0001975776-26-000006 · Source evidence
Reported offering amount: 10076464 USD. Reported amount sold: 10076464 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Ancilia Biosciences, Inc. research brief,” CIK 1975776, retrieved Nov. 19, 2026, 7:26 a.m.. Cite the specific accessions used. No amounts have been summed.